Vicore Pharma Holding AB announces that the U.S. Patent and Trademark Office has granted patent number US11,123,329 covering the use of C21 to treat infections caused by Severe Acute Respiratory Syndrome coronavirus, including SARS-CoV-2.
September 22, 2021
· 2 min read